Genomic and proteomic biomarker discovery in neurological disease

Ri Lee H. Robeson, Andrew M. Siegel, Travis Dunckley

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Technology for high-throughout scanning of the human genome and its encoded proteins have rapidly developed to allow systematic analyses of human disease. Application of these technologies is becoming an increasingly effective approach for identifying the biological basis of genetically complex neurological diseases. This review will highlight significant findings resulting from the use of a multitude of genomic and proteomic technologies toward biomarker discovery in neurological disorders. Through substantial discoveries have been made there is clearly significant promise and potential remaining to be fully realized through-increasing use of and further development of omic technologies.

Original languageEnglish (US)
Pages (from-to)73-86
Number of pages14
JournalBiomarker Insights
Volume2008
Issue number3
StatePublished - Feb 27 2008
Externally publishedYes

Fingerprint

Biomarkers
Proteomics
Technology
Human Genome
Nervous System Diseases
Genes
Scanning
Proteins

Keywords

  • aCGH
  • Alzheimer's disease
  • Biomarker
  • Gene expression profiling
  • Genomics
  • Neurodegeneration
  • Neurological disease
  • Parkinson's disease
  • Proteomics
  • SNP

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Biochemistry, medical

Cite this

Genomic and proteomic biomarker discovery in neurological disease. / Robeson, Ri Lee H.; Siegel, Andrew M.; Dunckley, Travis.

In: Biomarker Insights, Vol. 2008, No. 3, 27.02.2008, p. 73-86.

Research output: Contribution to journalReview article

Robeson, RLH, Siegel, AM & Dunckley, T 2008, 'Genomic and proteomic biomarker discovery in neurological disease', Biomarker Insights, vol. 2008, no. 3, pp. 73-86.
Robeson, Ri Lee H. ; Siegel, Andrew M. ; Dunckley, Travis. / Genomic and proteomic biomarker discovery in neurological disease. In: Biomarker Insights. 2008 ; Vol. 2008, No. 3. pp. 73-86.
@article{bfa36fcf105e4c27abff2f56d07b8bcb,
title = "Genomic and proteomic biomarker discovery in neurological disease",
abstract = "Technology for high-throughout scanning of the human genome and its encoded proteins have rapidly developed to allow systematic analyses of human disease. Application of these technologies is becoming an increasingly effective approach for identifying the biological basis of genetically complex neurological diseases. This review will highlight significant findings resulting from the use of a multitude of genomic and proteomic technologies toward biomarker discovery in neurological disorders. Through substantial discoveries have been made there is clearly significant promise and potential remaining to be fully realized through-increasing use of and further development of omic technologies.",
keywords = "aCGH, Alzheimer's disease, Biomarker, Gene expression profiling, Genomics, Neurodegeneration, Neurological disease, Parkinson's disease, Proteomics, SNP",
author = "Robeson, {Ri Lee H.} and Siegel, {Andrew M.} and Travis Dunckley",
year = "2008",
month = "2",
day = "27",
language = "English (US)",
volume = "2008",
pages = "73--86",
journal = "Biomarker Insights",
issn = "1177-2719",
publisher = "Libertas Academica Ltd.",
number = "3",

}

TY - JOUR

T1 - Genomic and proteomic biomarker discovery in neurological disease

AU - Robeson, Ri Lee H.

AU - Siegel, Andrew M.

AU - Dunckley, Travis

PY - 2008/2/27

Y1 - 2008/2/27

N2 - Technology for high-throughout scanning of the human genome and its encoded proteins have rapidly developed to allow systematic analyses of human disease. Application of these technologies is becoming an increasingly effective approach for identifying the biological basis of genetically complex neurological diseases. This review will highlight significant findings resulting from the use of a multitude of genomic and proteomic technologies toward biomarker discovery in neurological disorders. Through substantial discoveries have been made there is clearly significant promise and potential remaining to be fully realized through-increasing use of and further development of omic technologies.

AB - Technology for high-throughout scanning of the human genome and its encoded proteins have rapidly developed to allow systematic analyses of human disease. Application of these technologies is becoming an increasingly effective approach for identifying the biological basis of genetically complex neurological diseases. This review will highlight significant findings resulting from the use of a multitude of genomic and proteomic technologies toward biomarker discovery in neurological disorders. Through substantial discoveries have been made there is clearly significant promise and potential remaining to be fully realized through-increasing use of and further development of omic technologies.

KW - aCGH

KW - Alzheimer's disease

KW - Biomarker

KW - Gene expression profiling

KW - Genomics

KW - Neurodegeneration

KW - Neurological disease

KW - Parkinson's disease

KW - Proteomics

KW - SNP

UR - http://www.scopus.com/inward/record.url?scp=39549115229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39549115229&partnerID=8YFLogxK

M3 - Review article

VL - 2008

SP - 73

EP - 86

JO - Biomarker Insights

JF - Biomarker Insights

SN - 1177-2719

IS - 3

ER -